Page last updated: 2024-11-07

fluprednisolone and Metabolic Diseases

fluprednisolone has been researched along with Metabolic Diseases in 1 studies

Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiegel, G1
Kukwa, D1

Trials

1 trial available for fluprednisolone and Metabolic Diseases

ArticleYear
[Comparative studies on the effect of different glucocorticoids in the corticoid glucose tolerance test].
    Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1969, Volume: 2, Issue:1

    Topics: Betamethasone; Blood Glucose; Clinical Trials as Topic; Dexamethasone; Diabetes Mellitus; Fluprednis

1969